UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
发明人:
Edward A. Clark,Craig Chappell,Natalia V. Giltiay,Kevin Draves
申请号：
US14426623
公开号：
US20150238632A1
申请日:
2013.09.18
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The present invention provides compositions of blood dendritic cell antigen 2 (BDCA2) targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.
